EBS

Quote

Short

News

Articles

Message Board

Emergent Biosolutions Inc. (NYSE : EBS ) News

Emergent Biosolutions Inc. (NYSE: EBS) News Releases

EBS News Releases

February 26, 2026 04:01:00 pm

GlobeNewswire

Emergent BioSolutions Announces New $50 Million Stock Repurchase Program

February 25, 2026 05:35:57 pm

SeekingAlpha

Emergent Biosolutions Q4 2025 Earnings Preview

February 12, 2026 06:00:00 pm

GlobeNewswire

Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN® Nasal Spray Multipacks

February 12, 2026 09:02:20 am

GlobeNewswire

Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

January 14, 2026 11:55:59 pm

SeekingAlpha

Emergent BioSolutions Inc. (EBS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

January 14, 2026 08:00:00 am

GlobeNewswire

Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness

January 12, 2026 07:30:00 am

GlobeNewswire

Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation

January 08, 2026 04:30:00 pm

GlobeNewswire

Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026

January 08, 2026 08:00:00 am

GlobeNewswire

Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa

January 07, 2026 07:59:00 am

GlobeNewswire

Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Back to Start

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account